Wim Timens

Active 1985–2025

184
Papers
30,128
Citations
85
h-index
177
i10-index

Citations

Citations per year for Wim Timens1976: 1 citations1982: 1 citations1985: 1 citations1987: 5 citations1988: 7 citations1989: 7 citations1990: 5 citations1991: 6 citations1992: 13 citations1993: 11 citations1994: 12 citations1995: 8 citations1996: 25 citations1997: 23 citations1998: 21 citations1999: 14 citations2000: 41 citations2001: 32 citations2002: 32 citations2003: 65 citations2004: 62 citations2005: 86 citations2006: 95 citations2007: 95 citations2008: 104 citations2009: 123 citations2010: 97 citations2011: 143 citations2012: 186 citations2013: 261 citations2014: 218 citations2015: 258 citations2016: 219 citations2017: 206 citations2018: 176 citations2019: 614 citations2020: 2,321 citations2021: 1,939 citations2022: 1,228 citations2023: 707 citations2024: 1,052 citations2025: 513 citations2026: 15 citations1977–1981: no citations, so these years are not shown1983–1984: no citations, so these years are not shown1986: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,743 citing papers, 21.5% of this breakdownChina: 1,695 citing papers, 9.7% of this breakdownUnited Kingdom: 1,376 citing papers, 7.9% of this breakdownGermany: 971 citing papers, 5.6% of this breakdownItaly: 887 citing papers, 5.1% of this breakdownNetherlands: 869 citing papers, 5% of this breakdownCanada: 631 citing papers, 3.6% of this breakdownFrance: 621 citing papers, 3.6% of this breakdownAustralia: 549 citing papers, 3.1% of this breakdownSpain: 487 citing papers, 2.8% of this breakdownIndia: 408 citing papers, 2.3% of this breakdownJapan: 390 citing papers, 2.2% of this breakdown
0%21.5%Other 27.6%

Fields

  • Medicine70.8%
  • Biochemistry, Genetics and Molecular Biology16.9%
  • Immunology and Microbiology6.2%
  • Neuroscience1.3%
  • Environmental Science0.8%
  • Engineering0.8%
  • Other3.2%

Topics

  • COVID-19 Clinical Research Studies7.7%
  • SARS-CoV-2 and COVID-19 Research5%
  • Long-Term Effects of COVID-194.2%
  • Asthma and respiratory diseases3.6%
  • Chronic Obstructive Pulmonary Disease (COPD) Research3.5%
  • Lung Cancer Treatments and Mutations2.1%
  • Other73.9%

Coauthors

All papers

Open in search
  1. An integrated cell atlas of the lung in health and disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Chase J. Taylor, Thomas Walzthoeni, Chuan Xu, Linh T. Bui, Carlo De Donno, Leander Dony, Alen Faiz, Minzhe Guo, Austin J. Gutierrez, Lukas Heumos, Ni Huang, Ignacio L. Ibarra, Nathan D. Jackson, Preetish Kadur Lakshminarasimha Murthy, Mohammad Lotfollahi, Tracy Tabib, Carlos Talavera‐López, Kyle J. Travaglini, Anna Wilbrey-Clark, Kaylee B. Worlock, Masahiro Yoshida, Yuexin Chen, James S. Hagood, Ahmed Agami, Péter Horváth, Joakim Lundeberg, Charles‐Hugo Marquette, Gloria Pryhuber, Chistos Samakovlis, Xin Sun, Lorraine B. Ware, Kun Zhang, Maarten van den Berge, Yohan Bossé, Tushar Desai, Oliver Eickelberg, Naftali Kaminski, Mark A. Krasnow, Robert Lafyatis, Marko Nikolić, Joseph E. Powell, Jayaraj Rajagopal, Mauricio Rojas, Orit Rozenblatt–Rosen, Max A. Seibold, Dean Sheppard, Douglas P. Shepherd, Don D. Sin, Wim Timens, Alexander M. Tsankov, Jeffrey A. Whitsett, Yan Xu, Nicholas E. Banovich, Pascal Barbry, Thu Elizabeth Duong, Christine S. Falk, Kerstin B. Meyer, Jonathan A. Kropski, Dana Pe’er, Herbert B. Schiller, Purushothama Rao Tata, Joachim L. Schultze, Sara A. Teichmann, Alexander V. Misharin, Martijn C. Nawijn, Malte D. Luecken, Fabian J. Theis - Nature Medicine 2023 cited by 760

  2. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis

    Authors: , , , , , - The Journal of Pathology 2004 cited by 5,922

  3. A cellular census of human lungs identifies novel cell states in health and in asthma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Herbert B. Schiller, Fabian J. Theis, Maarten van den Berge, Martijn C. Nawijn, Sarah A. Teichmann - Nature Medicine 2019 cited by 971

  4. Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Shantanu Banerji, Gad Getz, Kwon-Sik Park, Daniel Rauh, Christian Grütter, Matthias Fischer, Laura Pasqualucci, Gavin Wright, Zoe Wainer, Prudence A. Russell, Iver Petersen, Yuan Chen, Erich Stoelben, Corinna Ludwig, Philipp A. Schnabel, Hans Hoffmann, Thomas Muley, Michael Brockmann, Walburga Engel-Riedel, Lucia Anna Muscarella, Vito Michele Fazio, Harry J.M. Groen, Wim Timens, Hannie Sietsma, Erik Thunnissen, Egbert F. Smit, Daniëlle A.M. Heideman, Peter J.F. Snijders, Federico Cappuzzo, Claudia Ligorio, Stefania Damiani, John K. Field, Steinar Solberg, Odd Terje Brustugun, Marius Lund‐Iversen, Jörg Sänger, Joachim H. Clement, Alex Soltermann, Holger Moch, Walter Weder, Benjamin Solomon, Jean‐Charles Soria, Pierre Validire, Benjamin Besse, Élisabeth Brambilla, Christian Brambilla, Sylvie Lantuéjoul, Philippe Lorimier, Peter M. Schneider, Michael Hallek, William Pao, Matthew Meyerson, Julien Sage, Jay Shendure, Robert C. Schneider, Reinhard Büttner, Jürgen Wolf, Peter Nürnberg, Sven Perner, Lukas C. Heukamp, Paul K. Brindle, Stefan A. Haas, Roman K. Thomas - Nature Genetics 2012 cited by 1,418

  5. The Pathology of Chronic Obstructive Pulmonary Disease

    Authors: , - Annual Review of Pathology Mechanisms of Disease 2008 cited by 838

  6. Angiotensin‐converting enzyme 2 (ACE2), SARS‐CoV‐2 and the pathophysiology of coronavirus disease 2019 (COVID‐19)

    Authors: , , , , , , , , , , , , - The Journal of Pathology 2020 cited by 1,104

  7. Whole-body CD8+ T cell visualization before and during cancer immunotherapy: a phase 1/2 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2022 cited by 127

  8. Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ayodeji Adegunsoye, Mary E. Strek, Margaret Neighbors, Xuting R. Sheng, Gunnar Guðmundsson, Vilmundur Guðnason, Hiroto Hatabu, David J. Lederer, Ani Manichaikul, John D. Newell, George O'connor, Victor E. Ortega, Hanfei Xu, Tasha E. Fingerlin, Yohan Bossé, Ke Hao, Philippe Joubert, David C. Nickle, Don D. Sin, Wim Timens, Dominic Furniss, Andrew P. Morris, Krina T. Zondervan, Ian P. Hall, Ian Sayers, Martin D. Tobin, Toby M. Maher, Michael H. Cho, Gary M. Hunninghake, David A. Schwartz, Brian L. Yaspan, Philip L. Molyneaux, Carlos Flores, Imre Noth, Gísli Jenkins, Louise V. Wain - American Journal of Respiratory and Critical Care Medicine 2019 cited by 341

  9. The Human Lung Cell Atlas: A High-Resolution Reference Map of the Human Lung in Health and Disease

    Authors: , , , , , , , , , , , , , , , , , , , - American Journal of Respiratory Cell and Molecular Biology 2019 cited by 265

  10. 89Zr-pembrolizumab imaging as a non-invasive approach to assess clinical response to PD-1 blockade in cancer

    Authors: , , , , , , , , , , , , , , , , , , , - Annals of Oncology 2021 cited by 95

  11. Human lung extracellular matrix hydrogels resemble the stiffness and viscoelasticity of native lung tissue

    Authors: , , , , , , , , , - American Journal of Physiology-Lung Cellular and Molecular Physiology 2020 cited by 159

  12. Lung ageing and COPD: is there a role for ageing in abnormal tissue repair?

    Authors: , , , , , - European Respiratory Review 2017 cited by 224

  13. Future perspective for the application of predictive biomarker testing in advanced stage non-small cell lung cancer

    Authors: , , , , , , , , , , , , , , , , , , , - The Lancet Regional Health - Europe 2024 cited by 46

  14. Prioritization of candidate causal genes for asthma in susceptibility loci derived from UK Biobank

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Communications Biology 2021 cited by 174

  15. Management of Lung Nodules Detected by Volume CT Scanning

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2009 cited by 822

  16. Developments in predictive biomarker testing and targeted therapy in advanced stage non-small cell lung cancer and their application across European countries

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Regional Health - Europe 2024 cited by 48

  17. Genetic variants associated with susceptibility to idiopathic pulmonary fibrosis in people of European ancestry: a genome-wide association study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Eunice Oballa, Yohan Bossé, David C. Nickle, Don D. Sin, Wim Timens, Nick Shrine, Ian Sayers, Ian P. Hall, Imre Noth, David A. Schwartz, Martin D. Tobin, Louise V. Wain, Gísli Jenkins - The Lancet Respiratory Medicine 2017 cited by 300

  18. Circulating tumor cells in advanced non-small cell lung cancer patients are associated with worse tumor response to checkpoint inhibitors

    Authors: , , , , , , - Journal for ImmunoTherapy of Cancer 2019 cited by 113

  19. Blood eosinophil count and airway epithelial transcriptome relationships in COPD versus asthma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Charles Auffray, Bertrand DeMeulder, Sven Erik‐Dahlen, Ian M. Adcock, Kian Fan Chung, Loems Ziegler‐Heitbrock, Peter J. Sterk, Dave Singh, Christopher E. Brightling, the U‐BIOPRED and the EvA study teams - Allergy 2019 cited by 66

  20. IL-33 Expression Is Lower in Current Smokers at both Transcriptomic and Protein Levels

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Maarten van den Berge - American Journal of Respiratory and Critical Care Medicine 2023 cited by 35

  21. Link between increased cellular senescence and extracellular matrix changes in COPD

    Authors: , , , , , , , - American Journal of Physiology-Lung Cellular and Molecular Physiology 2020 cited by 66

  22. Dynamic Changes of Circulating Tumor DNA Predict Clinical Outcome in Patients With Advanced Non–Small-Cell Lung Cancer Treated With Immune Checkpoint Inhibitors

    Authors: , , , , , , , , , , , , , , , , , - JCO Precision Oncology 2021 cited by 61

  23. Recent advances in chronic obstructive pulmonary disease pathogenesis: from disease mechanisms to precision medicine

    Authors: , , , , - The Journal of Pathology 2019 cited by 207

  24. Genetic loci associated with chronic obstructive pulmonary disease overlap with loci for lung function and pulmonary fibrosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Matthijs Oudkerk, Harry J.M. Groen, Nicholas Locantore, Ruth Tal‐Singer, Stephen I. Rennard, Jørgen Vestbo, Wim Timens, Peter D. Paré, Jeanne C. Latourelle, Josée Dupuis, George O'connor, Jemma B. Wilk, Woo Jin Kim, Mi Kyeong Lee, Yeon‐Mok Oh, Judith M. Vonk, Harry J. de Koning, Shuguang Leng, Steven A. Belinsky, Yohannes Tesfaigzi, Ani Manichaikul, Xin‐Qun Wang, Stephen S. Rich, R. Graham Barr, David Sparrow, Augusto A. Litonjua, Per Bakke, Amund Gulsvik, Lies Lahousse, Guy Brusselle, Bruno H. Stricker, André G. Uitterlinden, Elizabeth J. Ampleford, Eugene R. Bleecker, Prescott G. Woodruff, Deborah A. Meyers, Dandi Qiao, David A. Lomas, Jae‐Joon Yim, Deog Kyeom Kim, I Hawryłkiewicz, Paweł Śliwiński, Megan Hardin, Tasha E. Fingerlin, David A. Schwartz, Dirkje S. Postma, William MacNee, Martin D. Tobin, Edwin K. Silverman, H. Marike Boezen, Michael H. Cho - Nature Genetics 2017 cited by 442